Advanced Biomed (ADVB) said Friday it has raised about $6.6 million from the initial public offering of 1.6 million shares at $4.00 per share.
The biotechnology company said it has granted its underwriter a 45-day option to buy up to 246,000 additional shares. Craft Capital Management acted as underwriter for the offering.
The shares started trading on Nasdaq Thursday.
Price: 3.67, Change: +0.02, Percent Change: +0.66
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。